stoxline Quote Chart Rank Option Currency Glossary
Inogen, Inc. (INGN)
8.95  -0.05 (-0.55%)    07-12 13:36
Open: 9.18
High: 9.365
Volume: 68,983
Pre. Close: 9
Low: 8.95
Market Cap: 211(M)
Technical analysis
2024-07-12 1:21:33 PM
Short term     
Mid term     
Targets 6-month :  10.93 1-year :  12.77
Resists First :  9.36 Second :  10.93
Pivot price 8.24
Supports First :  7.97 Second :  7.11
MAs MA(5) :  8.81 MA(20) :  8.08
MA(100) :  7.76 MA(250) :  6.73
MACD MACD :  0.2 Signal :  0
%K %D K(14,3) :  82.1 D(3) :  83.6
RSI RSI(14): 62
52-week High :  10.64 Low :  4.13
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ INGN ] has closed below upper band by 4.6%. Bollinger Bands are 19.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.16 - 9.21 9.21 - 9.26
Low: 8.6 - 8.64 8.64 - 8.69
Close: 8.93 - 9 9 - 9.07
Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Headline News

Mon, 08 Jul 2024
PNC Financial Services Group Inc. Increases Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World

Wed, 03 Jul 2024
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development - Business Wire

Mon, 01 Jul 2024
Inogen: Improving, But Still Struggling For Air (NASDAQ:INGN) - Seeking Alpha

Mon, 24 Jun 2024
Inogen (NASDAQ:INGN) Raised to "Hold" at - MarketBeat

Thu, 09 May 2024
Inogen First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Tue, 07 May 2024
Inogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on Growth - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 24 (M)
Shares Float 20 (M)
Held by Insiders 1.7 (%)
Held by Institutions 99.9 (%)
Shares Short 1,450 (K)
Shares Short P.Month 1,530 (K)
Stock Financials
EPS -4.16
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 8.14
Profit Margin -30.1 %
Operating Margin -19.9 %
Return on Assets (ttm) -10.7 %
Return on Equity (ttm) -40.9 %
Qtrly Rev. Growth 8.1 %
Gross Profit (p.s.) 0
Sales Per Share 13.63
EBITDA (p.s.) -1.72
Qtrly Earnings Growth 0 %
Operating Cash Flow -2 (M)
Levered Free Cash Flow 4 (M)
Stock Valuations
PE Ratio -2.18
PEG Ratio 0
Price to Book value 1.11
Price to Sales 0.66
Price to Cash Flow -127.03
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android